Premium
Etretinate and visual function: a 1‐year follow‐up study
Author(s) -
PITTS J. F.,
MACKIE RONA M.,
DUTTON G. N.,
MCCLURE ELIZABETH A.,
ALLAN D.
Publication year - 1991
Publication title -
british journal of dermatology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.304
H-Index - 179
eISSN - 1365-2133
pISSN - 0007-0963
DOI - 10.1111/j.1365-2133.1991.tb06039.x
Subject(s) - library science , medicine , history , ophthalmology , computer science
Summary Concern has been expressed in the literature that the drug etretinate may be potentially retinotoxic. Four patients are reported who have received long‐term treatment with etretinate and who have undergone detailed evaluation for the development of visual dysfunction over a 1‐year period. Despite prolonged treatment and high total doses no evidence of ocular toxicity attributable to the drug was found in any of the patients.